(VKTX) Viking Therapeutics - Performance -44.7% in 12m
VKTX performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
38.37%
#11 in Peer-Group
Rel. Strength
10.66%
#6859 in Stock-Universe
Total Return 12m
-44.74%
#124 in Peer-Group
Total Return 5y
323.27%
#4 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 78.03 USD |
| 52 Week Low | 19.98 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 74.09 |
| Buy/Sell Signal +-5 | 1.06 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: VKTX (-44.7%) vs XBI (-8.5%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
0.07% | 70.8% | 77.8% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.62% | -7.07% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
2.72% | -1.16% | 36% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-1.73% | 30.3% | -4.82% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
2.97% | -9.23% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
15% | 42% | -4.19% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-5.87% | 54.7% | -9.25% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
4.56% | 32% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: VKTX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for VKTX
| Total Return (including Dividends) | VKTX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 1.29% | 1.17% | 4.68% |
| 3 Months | 32.47% | 16.79% | 24.35% |
| 12 Months | -44.74% | -8.54% | 14.02% |
| 5 Years | 323.27% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | VKTX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -19.4% | 4.4% | 81% |
| 3 Months | 42% | 78.8% | 96.9% |
| 12 Months | -86.2% | -85.8% | 44.9% |
| 5 Years | 73.4% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th65.50 | 0.12% | -3.24% |
| 3 Month | %th65.00 | 13.42% | 6.53% |
| 12 Month | %th38.00 | -39.58% | -51.53% |
| 5 Years | %th98.50 | 458.48% | 99.82% |
FAQs
Does Viking Therapeutics (VKTX) outperform the market?
No,
over the last 12 months VKTX made -44.74%, while its related Sector, the SPDR S&P Biotech (XBI) made -8.54%.
Over the last 3 months VKTX made 32.47%, while XBI made 16.79%.
Performance Comparison VKTX vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
VKTX vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 5.2% | -3.4% | -39.4% | -59% |
| US NASDAQ 100 | QQQ | 5.6% | -3.8% | -40% | -57% |
| German DAX 40 | DAX | 6.3% | 2.9% | -51.5% | -74% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 5.7% | -2.1% | -42.8% | -65% |
| Hongkong Hang Seng | HSI | 4.8% | -4.1% | -58.8% | -86% |
| India NIFTY 50 | INDA | 6.2% | -0.3% | -39.7% | -44% |
| Brasil Bovespa | EWZ | 4.8% | -6.4% | -64.4% | -55% |
VKTX vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 6.8% | -3.1% | -43.5% | -70% |
| Consumer Discretionary | XLY | 4.6% | -3.2% | -31.7% | -63% |
| Consumer Staples | XLP | 4.9% | 0% | -41% | -54% |
| Energy | XLE | 3.8% | -3.9% | -35.3% | -45% |
| Financial | XLF | 4.8% | -2.8% | -44.3% | -75% |
| Health Care | XLV | 5.9% | -0% | -32% | -40% |
| Industrial | XLI | 5.1% | -2.1% | -47.2% | -70% |
| Materials | XLB | 2.3% | -3.3% | -43.9% | -50% |
| Real Estate | XLRE | 5.5% | 0.6% | -39.1% | -57% |
| Technology | XLK | 4.9% | -6.7% | -41.7% | -55% |
| Utilities | XLU | 6.2% | -0.2% | -42.6% | -68% |
| Aerospace & Defense | XAR | 7.3% | -4.1% | -58% | -93% |
| Biotech | XBI | 3.6% | 0.1% | -26.2% | -36% |
| Homebuilder | XHB | 2.3% | -6.7% | -32.2% | -49% |
| Retail | XRT | 1.8% | -1.9% | -35.1% | -56% |
VKTX vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 3.5% | -4.05% | -31.0% | -38% |
| Natural Gas | UNG | 6.6% | 12.5% | -22.6% | -41% |
| Gold | GLD | 5.6% | 0.7% | -60% | -86% |
| Silver | SLV | 4.3% | -1.2% | -56.7% | -64% |
| Copper | CPER | 5.5% | -4.3% | -56.5% | -57% |
VKTX vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 7.5% | -1% | -36% | -43% |
| iShares High Yield Corp. Bond | HYG | 6.3% | -0.5% | -38.3% | -55% |